Study of treatment with deferoxamine (DFX) in subcutaneous perfusion for patients diagnosed of myelodysplastic syndrome with iron overload.

被引：0
|
作者：
Villegas, A [1 ]
Ropero, P [1 ]
Barrio, CG [1 ]
Gonzalez, FA [1 ]
Arrizabalaga, B [1 ]
Remacha, A [1 ]
del Arco, A [1 ]
Gilsanz, F [1 ]
Peñalver, MA [1 ]
Murga, MJ [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5053
引用
收藏
页码：333B / 333B
页数：1
相关论文
共 50 条
  • [21] Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices
    Raptis, Anastasios
    Duh, Mei Sheng
    Wang, Si-Tien
    Dial, Ellison
    Fanourgiakis, Ilias
    Fortner, Barry
    Paley, Carole
    Mody-Patel, Nikita
    Corral, Mitra
    Scott, Jeffrey
    TRANSFUSION, 2010, 50 (01) : 190 - 199
  • [22] Role of private practices in the management of patients with myelodysplastic syndrome: Diagnostic routines, risk stratification and treatment of iron overload
    Nolte, F.
    Schumann, C.
    Strohbach, F.
    Saati, C.
    Herrenberger, J.
    Kingreen, D.
    Mohr, B.
    Kuehn, G.
    Sauer, A.
    Ludwig, F.
    Ostermann, G.
    Hofmann, W-K
    ONKOLOGIE, 2010, 33 : 37 - 38
  • [23] Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort study
    van Zuijdewijn, Camiel L. M. de Roij
    Westerweel, Peter E.
    Schipperus, Martin R.
    Pruijt, Johannes F. M.
    van de Loosdrecht, Arjan A.
    Beeker, Aart
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2023, 30 (03) : 314 - 318
  • [24] IRON CHELATION THERAPY WITH THE DEFERIPRONE PLUS DEFEROXAMINE REGIMEN USED IN PATIENTS WITH THALASSEMIA SAFELY AND EFFECTIVELY REVERSED IRON OVERLOAD-RELATED HEART FAILURE IN A PATIENT WITH MYELODYSPLASTIC SYNDROME
    Pinto, V.
    Balocco, M.
    Quintino, S.
    Lamagna, M.
    Carrara, P.
    Forni, G. L.
    HAEMATOLOGICA, 2015, 100 : 105 - 106
  • [25] Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome
    Escudero-Vilaplana, V.
    Garcia-Gonzalez, X.
    Osorio-Prendes, S.
    Romero-Jimenez, R. M.
    Sanjurjo-Saez, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (01) : 59 - 63
  • [26] Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
    Jabbour, Elias
    Kantarjian, Hagop M.
    Koller, Charles
    Taher, Ali
    CANCER, 2008, 112 (05) : 1089 - 1095
  • [27] Combination Therapy of Deferasirox and Deferoxamine As Paregoric Treatment of Severe Iron Overload in Patients with Thalassemia Major
    Ladis, Vassilis
    Kyriacopoulou, Dimitra
    Stokidis, Konstantinos
    Moira, Aggeliki
    Kattamis, Antonios
    BLOOD, 2012, 120 (21)
  • [28] TOXIC EFFECTS OF HIGH-DOSE DEFEROXAMINE TREATMENT IN PATIENTS WITH IRON OVERLOAD - AN ELECTROPHYSIOLOGICAL STUDY OF CEREBRAL AND VISUAL FUNCTION
    MARCIANI, MG
    CIANCIULLI, P
    STEFANI, N
    STEFANINI, F
    PERONI, L
    SABBADINI, M
    MASCHIO, M
    TRUA, G
    PAPA, G
    HAEMATOLOGICA, 1991, 76 (02) : 131 - 134
  • [29] The effect of transfusion dependency and secondary iron overload on survival of patients with myelodysplastic syndrome.
    Malcovati, L
    Della Porta, MG
    Pascutto, C
    Invernizzi, R
    Passamonti, F
    Arcaini, L
    Maffioli, M
    Rumi, E
    Travaglino, E
    Bernasconi, P
    Lazzarino, M
    Cazzola, M
    BLOOD, 2005, 106 (11) : 233A - 234A
  • [30] INFERIOR OUTCOME IN LOW-RISK MYELODYSPLASTIC SYNDROME PATIENTS EXHIBITING IRON OVERLOAD
    Sumoza, M.
    Yellapragada, S.
    Roque, W.
    Mims, M.
    Rivero, G.
    LEUKEMIA RESEARCH, 2015, 39 : S138 - S138
12345